Patent: 5,366,728
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,366,728
Title: | Stable forms of antigenic Taenia ovis polypeptides |
Abstract: | Stable forms of Taenia ovis peptide antigens, such as portions of a T. ovis oncosphere antigen which runs as a 47-52 kDa doublet, are suitable for use in vaccines to protect ruminants against infection by cestode parasites. The antigens are preferably obtained by isolation and expression of the DNA encoding them in recombinant host cells. Aspects of the invention include DNA encoding T. ovis antigens, vectors containing such DNA and host cells which express the T. ovis antigens. |
Inventor(s): | Harrison; Gavin B. L. (Upper Hutt, NZ), Dempster; Robert P. (Upper Hutt, NZ), Rickard; Michael D. (Werribee, AU), Lightowlers; Marshall W. (Victoria, AU), Heath; David D. (Paremata, NZ), Lawrence; Stephen B. (Upper Hutt, NZ), O\'Hoy; Kim L. (Pascoe Vale, AU) |
Assignee: | Pitman-Moore New Zealand Limited (Upper Hutt, NZ) The University of Melbourne (Melbourne, AU) Her Majestry the Queen in right of New Zealand through the Ministry of (Wellington, NZ) |
Application Number: | 07/969,450 |
Patent Claims: | see list of patent claims |
Details for Patent 5,366,728
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | See Plans and Pricing | 2008-01-06 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | See Plans and Pricing | 2008-01-06 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | See Plans and Pricing | 2008-01-06 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |